Latest Market News

Cambium Bio has raised A$2.12 million through a fully subscribed placement led by Taiwanese institutional investor Da Jyun Capital, supporting the initiation of pivotal Phase 3 trials for its lead ophthalmology candidate.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

Jatcorp Limited reported a robust 76% revenue increase in Q4 FY25, driven by strong Moroka® sales and expanded manufacturing capabilities, setting ambitious growth targets for FY26.

Stelar Metals has been granted a new exploration licence in South Australia targeting titanium-rich heavy mineral sands, while also uncovering promising tin potential at its New South Wales Trident Project.

Octava Minerals has successfully completed the initial phase of its $1.5 million capital raise, positioning the company to advance exploration and due diligence at its promising Federation Copper-Zinc-Silver Project.

KGL Resources has leveraged cutting-edge integrated 3D inversion modelling to reveal multiple high-priority exploration targets at its Jervois and Unca Creek tenements, suggesting a larger and deeper mineral system than previously known.

Diatreme Resources has achieved a significant milestone with its Northern Silica Project awarded Major Project Status and a 278% upgrade in its Si2 Deposit resource, positioning the company for long-term growth in the critical minerals sector.

Ausmon Resources reports promising assay results from its Limestone Coast Project, revealing significant rare earth element concentrations that bolster its exploration prospects in South Australia.

Ballymore Resources’ latest drilling at the Dittmer Project in North Queensland confirms expanding high-grade gold, silver, and copper mineralisation, with promising deep extensions identified. The company is advancing towards mining lease approval to unlock further underground exploration.

Gladiator Resources reported promising uranium and rare metal findings at its Tanzanian projects while initiating legal action over alleged defamation, all against a backdrop of cautious cash management.

Uvre Limited has secured a transformative portfolio of New Zealand gold projects, including the high-grade Waitekauri asset, backed by a $4 million capital raise and new board appointments. The company is gearing up for its maiden drilling campaign this September.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.